JP5269633B2 - 栄養素及び/又は医療物質の適性に関連する提案及び/又は情報を提供するための方法及びシステム - Google Patents
栄養素及び/又は医療物質の適性に関連する提案及び/又は情報を提供するための方法及びシステム Download PDFInfo
- Publication number
- JP5269633B2 JP5269633B2 JP2009020021A JP2009020021A JP5269633B2 JP 5269633 B2 JP5269633 B2 JP 5269633B2 JP 2009020021 A JP2009020021 A JP 2009020021A JP 2009020021 A JP2009020021 A JP 2009020021A JP 5269633 B2 JP5269633 B2 JP 5269633B2
- Authority
- JP
- Japan
- Prior art keywords
- user
- information
- nutrients
- medical
- database
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000015097 nutrients Nutrition 0.000 title claims description 175
- 239000000126 substance Substances 0.000 title claims description 155
- 238000000034 method Methods 0.000 title claims description 44
- 235000016709 nutrition Nutrition 0.000 claims abstract description 119
- 230000035764 nutrition Effects 0.000 claims abstract description 84
- 230000036541 health Effects 0.000 claims abstract description 40
- 230000002068 genetic effect Effects 0.000 claims abstract description 35
- 108090000623 proteins and genes Proteins 0.000 claims description 66
- 230000006378 damage Effects 0.000 claims description 13
- 230000008821 health effect Effects 0.000 claims description 9
- 238000004891 communication Methods 0.000 claims description 6
- 230000037406 food intake Effects 0.000 claims description 6
- 230000000172 allergic effect Effects 0.000 claims description 5
- 208000010668 atopic eczema Diseases 0.000 claims description 5
- 239000012567 medical material Substances 0.000 claims description 3
- 230000001186 cumulative effect Effects 0.000 claims 6
- 230000035876 healing Effects 0.000 claims 1
- FFNMBRCFFADNAO-UHFFFAOYSA-N pirenzepine hydrochloride Chemical compound [H+].[H+].[Cl-].[Cl-].C1CN(C)CCN1CC(=O)N1C2=NC=CC=C2NC(=O)C2=CC=CC=C21 FFNMBRCFFADNAO-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 46
- 229940079593 drug Drugs 0.000 abstract description 44
- 238000011160 research Methods 0.000 abstract description 33
- 230000007613 environmental effect Effects 0.000 abstract description 21
- 230000002503 metabolic effect Effects 0.000 abstract description 5
- 238000011282 treatment Methods 0.000 abstract description 4
- 230000000050 nutritive effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 98
- 201000010099 disease Diseases 0.000 description 97
- 235000013305 food Nutrition 0.000 description 90
- 230000007246 mechanism Effects 0.000 description 54
- 239000000047 product Substances 0.000 description 41
- 230000000694 effects Effects 0.000 description 25
- 230000008859 change Effects 0.000 description 15
- 239000004615 ingredient Substances 0.000 description 15
- 235000012054 meals Nutrition 0.000 description 15
- 239000000575 pesticide Substances 0.000 description 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 239000000463 material Substances 0.000 description 11
- 239000000654 additive Substances 0.000 description 10
- 229940014144 folate Drugs 0.000 description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 10
- 235000019152 folic acid Nutrition 0.000 description 10
- 239000011724 folic acid Substances 0.000 description 10
- 238000003908 quality control method Methods 0.000 description 10
- 235000002639 sodium chloride Nutrition 0.000 description 10
- 208000024172 Cardiovascular disease Diseases 0.000 description 9
- 230000005540 biological transmission Effects 0.000 description 9
- 235000019577 caloric intake Nutrition 0.000 description 9
- 102000005954 Methylenetetrahydrofolate Reductase (NADPH2) Human genes 0.000 description 8
- 108010030837 Methylenetetrahydrofolate Reductase (NADPH2) Proteins 0.000 description 8
- 206010020751 Hypersensitivity Diseases 0.000 description 7
- 241000656145 Thyrsites atun Species 0.000 description 7
- 230000007815 allergy Effects 0.000 description 7
- 150000001720 carbohydrates Chemical class 0.000 description 7
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 7
- 230000037213 diet Effects 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 239000000262 estrogen Substances 0.000 description 6
- 229940011871 estrogen Drugs 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 235000020938 metabolic status Nutrition 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 6
- 241000251468 Actinopterygii Species 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 235000019688 fish Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 230000002301 combined effect Effects 0.000 description 4
- 235000006694 eating habits Nutrition 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 208000019622 heart disease Diseases 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011785 micronutrient Substances 0.000 description 4
- 235000013369 micronutrients Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 150000003904 phospholipids Chemical class 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 235000021003 saturated fats Nutrition 0.000 description 4
- 235000021081 unsaturated fats Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000186781 Listeria Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 102000029797 Prion Human genes 0.000 description 3
- 108091000054 Prion Proteins 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 235000016213 coffee Nutrition 0.000 description 3
- 235000013353 coffee beverage Nutrition 0.000 description 3
- 239000000306 component Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- 229910052753 mercury Inorganic materials 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 239000003471 mutagenic agent Substances 0.000 description 3
- 231100000707 mutagenic chemical Toxicity 0.000 description 3
- 150000002823 nitrates Chemical class 0.000 description 3
- 150000002826 nitrites Chemical class 0.000 description 3
- 235000021049 nutrient content Nutrition 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 239000003075 phytoestrogen Substances 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 108010064733 Angiotensins Proteins 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 2
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 244000203593 Piper nigrum Species 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 239000000674 adrenergic antagonist Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 102000030484 alpha-2 Adrenergic Receptor Human genes 0.000 description 2
- 108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 208000019553 vascular disease Diseases 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000020446 Cardiac disease Diseases 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 241000277301 Esociformes Species 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 101150017040 I gene Proteins 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 235000016357 Mirtillo rosso Nutrition 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000364051 Pima Species 0.000 description 1
- 108010077971 Plasminogen Inactivators Proteins 0.000 description 1
- 102000010752 Plasminogen Inactivators Human genes 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013473 artificial intelligence Methods 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- 102000016967 beta-1 Adrenergic Receptors Human genes 0.000 description 1
- 108010014494 beta-1 Adrenergic Receptors Proteins 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 108010015408 connexin 37 Proteins 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000020979 dietary recommendations Nutrition 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000015219 food category Nutrition 0.000 description 1
- 235000019138 food restriction Nutrition 0.000 description 1
- -1 for example Proteins 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000012020 french fries Nutrition 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 101150090192 how gene Proteins 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000012067 mathematical method Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 235000015074 other food component Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000002797 plasminogen activator inhibitor Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 235000000053 special nutrition Nutrition 0.000 description 1
- 235000013403 specialized food Nutrition 0.000 description 1
- 230000037078 sports performance Effects 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/002—Compounding apparatus specially for enteral or parenteral nutritive solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/80—Mixing plants; Combinations of mixers
- B01F33/84—Mixing plants with mixing receptacles receiving material dispensed from several component receptacles, e.g. paint tins
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/10—Office automation; Time management
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/12—Hotels or restaurants
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/30—Data warehousing; Computing architectures
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
- B01F2101/06—Mixing of food ingredients
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
- B01F2101/22—Mixing of ingredients for pharmaceutical or medical compositions
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Business, Economics & Management (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Theoretical Computer Science (AREA)
- Primary Health Care (AREA)
- Tourism & Hospitality (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Strategic Management (AREA)
- Human Resources & Organizations (AREA)
- General Business, Economics & Management (AREA)
- Epidemiology (AREA)
- Economics (AREA)
- Marketing (AREA)
- General Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Evolutionary Biology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioethics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Databases & Information Systems (AREA)
- Entrepreneurship & Innovation (AREA)
- Nutrition Science (AREA)
- Data Mining & Analysis (AREA)
- Quality & Reliability (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Operations Research (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
614・・・品質管理
616・・・科学的調査
618・・・販売業者
620・・・レストラン
628・・・デジタルテレビ。
Claims (14)
- ユーザのデータ端末を介して通信することによって、ユーザに対する栄養素及び/又は医療物質の適性に関連する提案及び/又は情報を提供するための方法であって、
1)a.或る確率で治癒するように又は害を与えるように少なくとも1つの健康特性へ影響を与える少なくとも1つの遺伝子及び/又は機能状態にある少なくとも1つの遺伝子の確率重み付け係数に関する情報を、所定のフォーマットでデータ機器によってデータベースに伝達すること、
b.或る確率で治癒するように又は害を与えるように前記健康特性に影響を与える栄養素及び/又は医療物質の確率重み付け係数に関する情報を、所定の情報フォーマットでデータ機器によって前記データベースに伝達すること、
c.ユーザの遺伝子及び/又は機能状態にあるユーザの遺伝子の指示を所定のフォーマットでデータ機器によって前記データベースに伝達すること、
によってサーバでデータベースを作成する段階と、
2)指示されたユーザの遺伝子と少なくとも1つの健康特性との間の確率重み付け係数をサーバで選択し、前記遺伝子は、通常及び/又は機能状態にある時に、健康特性へ影響を与える段階と、
3)段階2)の前記健康特性と或る確率で治癒するように又は害を与えるように前記健康特性に影響を与える栄養素及び/又は医療物質との間の確率重み付け係数をサーバで選択する段階と、
4)最大に治癒するように前記健康特性に影響する栄養素及び/又は医療物質が最適な提案として提供されるように、ユーザに対する栄養素及び/又は医療物質の適性を述べるために或る順番で、段階3)で決定された確率重み付け係数をサーバで配列する段階と、
5)ユーザのデータ端末を介してユーザに前記最適な提案をサーバによって伝達する段階と
を具備することを特徴とする方法。 - データベースは、以下の群から選択されるべき少なくとも1対に対する少なくとも1つの確率重み付け係数によって伝達され、少なくとも1つの栄養素及び/又は医療物質と共に少なくとも1つの遺伝子は、或る確率で治癒するように又は害を与えるように少なくとも1つの健康特性に影響を与え、ユーザは、或る確率で少なくとも1つの栄養素及び/又は医療物質にアレルギであることを特徴とする請求項1に記載の方法。
- 或る確率及び栄養素及び/又は医療物質に関する確率で治癒するように又は害を与えるように前記健康特性に影響を与える栄養素及び/又は医療物質は、ユーザに前記栄養素及び/又は医療物質の適性を述べる情報の定義が、前記健康特性への治癒効果を有する最高確率を有する栄養素及び/又は医療物質が最重要として判別されるような順序に配置される時に使用されたことを特徴とする請求項1又は2に記載の方法。
- ユーザによって消費され又は消費するよう意図される少なくとも1つの栄養素及び/又は医療物質に関する情報は、データ端末機器の支援で配信されることを特徴とする請求項1に記載の方法。
- ユーザの遺伝子情報に追加して、ユーザの識別情報(ID)、少なくとも一部のユーザの遺伝子マップ、ユーザの体重、ユーザの身長、ユーザの性別及び/又はユーザの年齢は、データベースに伝達され、ユーザによって消費される栄養情報及び/又は医療物質の他に、データ端末機器は、栄養素及び/又は医療物質の量を配信するために使用され、ユーザによって消費される栄養素及び量の栄養情報及び/又は医療物質の情報は、累積的に前記データベースに登録され、それらは、ユーザの識別情報に結合されることができることを特徴とする請求項1に記載の方法。
- 個人に合わせた摂取限度は、少なくとも1つの栄養素及び/又は医療物質に設定され、通知は、所定の時間期間の間における前記栄養素及び/又は医療物質の累積量がユーザについて定義される前記個人に合わせた摂取限度より高いか又は低い場合、形成されることを特徴とする請求項1〜5のうち何れか1項に記載の方法。
- 選択された時間期間内にユーザによって消費される栄養素の物質及び/又は医療物質の累積量は、前記栄養素及び/又は医療物質に設定された摂取限度と比較され、少なくとも1つの栄養素又は医療物質が選択され、前記時間期間における累積量は、所定の摂取限度の領域内ではなく、治癒するように或る健康特性に影響を与える前記物質に対する確率重み付け係数の値が所定の限度を超える場合、前記栄養素及び/又は医療物質は、前記ユーザが摂取するよう提案されることを特徴とする請求項1〜6のうち何れか1項に記載の方法。
- 少なくとも1つの以下のシステムで情報をデータベースに配信する方法であって、インターネットを介して、又はデジタルテレビを介して移動局、PDA装置、スマートカード、電磁カードの支援を備えることを特徴とする請求項1〜7のうち何れか1項に記載の方法。
- ユーザのデータ端末を介して通信することによって、ユーザに対する栄養素及び/又は医療物質の適性に関連する提案及び/又は情報を提供するためのシステムであって、
1)a.或る確率で治癒するように又は害を与えるように少なくとも1つの健康特性へ影響を与える少なくとも1つの遺伝子及び/又は機能状態にある少なくとも1つの遺伝子の確率重み付け係数に関する情報を、所定のフォーマットでデータ機器によってデータベースに伝達すること、
b.或る確率で治癒するように又は害を与えるように前記健康特性に影響を与える栄養素及び/又は医療物質の確率重み付け係数に関する情報を、所定のフォーマットでデータ機器によって前記データベースに伝達すること、
c.ユーザの遺伝子及び/又は機能状態にあるユーザの遺伝子の指示を所定のフォーマットでデータ機器によって前記データベースに伝達すること
によってサーバでデータベースを作成する段階と、
2)指示されたユーザの遺伝子と少なくとも1つの健康特性との間の確率重み付け係数をサーバで選択し、前記遺伝子は、通常及び/又は機能状態にある時に、健康特性へ影響を与える段階と、
3)段階2)の前記健康特性と、或る確率で治癒するように又は害を与えるように前記健康特性に影響を与える栄養素及び/又は医療物質との間の確率重み付け係数をサーバで選択する段階と、
4)最大に治癒するように前記健康特性に影響する栄養素及び/又は医療物質が最適な提案として提供されるように、ユーザに対する栄養素及び/又は医療物質の適性を述べるために或る順番で、段階3)で決定された確率重み付け係数をサーバで配列する段階と、
5)前記サーバとデータ通信しているユーザのデータ端末を介してサーバからユーザに前記最適な提案を伝達する段階と
を行うことを特徴とするシステム。 - システムは、少なくとも1つのデータ端末機器を具備し、ユーザによって摂取されたか又は摂取するよう意図された少なくとも1つの栄養素及び/又は医療物質に関する情報は、ユーザ識別情報と共にデータベースに配信され、システムは、累積的にユーザによって摂取された栄養素及び/又は医療物質の量をデータベースに登録し、それらをユーザの識別情報に結合できるようさらに配置されることを特徴とする請求項9に記載のシステム。
- データベースは、少なくとも1つの栄養素及び/又は医療物質に対する個人に合わせた摂取限度を具備し、システムは、所定の時間期間における前記栄養素及び/又は医療物質の累積量が、前記栄養素及び/又は医療物質のユーザについて定義される個人に合わせた摂取限度より高いか又は低い場合、通知を形成するよう配置されることを特徴とする請求項9又は10に記載のシステム。
- システムは、少なくとも一つの栄養素又は医療物質を選択するために、選択された時間期間内にユーザによって消費された栄養素及び/又は医療物質の累積物質量と、前記栄養素及び/又は医療物質について設定された摂取限度とを比較し、前記時間期間における累積量が定義された摂取限度より低く、治癒するように或る確率を含む前記物質に対する確率重み付け係数の値が予め設定された限度より高い場合、前記ユーザによって消費される前記栄養素及び/又は医療物質を提案することを特徴とする請求項9又は10に記載のシステム。
- システムは、情報をデータベースに配信するための少なくとも1つの以下の手段を具備し、インターネットを介して、又はデジタルテレビを介して移動局、PDA装置、スマートカード、電磁カードの支援を備えることを特徴とする請求項9〜12のうち何れか1項に記載のシステム。
- ユーザのデータ端末を介して通信することによってユーザに対する栄養素及び/又は医療物質の適性に関する提案及び/又は情報を提供するためのプログラムを格納したコンピュータ読み取り可能な媒体であって、
1)a.或る確率で治癒するように又は害を与えるように少なくとも1つの健康特性へ影響を与える少なくとも1つの遺伝子及び/又は機能状態にある少なくとも1つの遺伝子の確率重み付け係数に関する情報が、所定の情報フォーマットでデータ機器によってデータベースに伝達され、前記データベースによって前記情報を受信すること
b.或る確率で治癒するように又は害を与えるように前記健康特性に影響する栄養素及び/又は医療物質の確率重み付け係数に関する情報が、所定のフォーマットでデータ機器によって伝達され、前記データベースによって受信すること
c.ユーザの遺伝子及び/又は機能状態にあるユーザの遺伝子の指示が所定のフォーマットでデータ機器によって伝達され、前記データベースによって指示を受信すること
によってサーバでデータベースを作成し、
2)指示されたユーザの遺伝子と少なくとも1つの健康特性との間で確率重み付け係数をサーバで選択し、前記遺伝子は、通常及び/又は機能状態にある時に、健康特性へ影響を与え、
3)段階2)の前記健康特性と、或る確率で治癒するように又は害を与えるように前記健康特性に影響する栄養素及び/又は医療物質との間で確率重み付け係数をサーバで選択し、
4)最大に治癒するように前記健康要素に影響する栄養素及び/又は医療物質が最適な提案として提供されるように、ユーザに対する栄養素及び/又は医療物質の適性を述べるために或る順番で、段階3)で決定された確率重み付け係数をサーバで配列し、
5)前記プログラムがサーバで動作する時、前記サーバとデータ通信しているユーザのデータ端末を介してサーバからユーザに前記最適な提案を伝達する
ように構成されることを特徴とするプログラムを格納したコンピュータ読み取り可能な媒体。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20012593 | 2001-12-28 | ||
FI20012593A FI20012593A0 (fi) | 2001-12-28 | 2001-12-28 | Menetelmä ja järjestelmä ravitsemustietopalvelun järjestämiseksi |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003556935A Division JP2005513678A (ja) | 2001-12-28 | 2002-12-23 | 情報サービスを配列して栄養及び/又は薬剤を決定するための方法及び機構 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012231808A Division JP2013037724A (ja) | 2001-12-28 | 2012-10-19 | 栄養素及び/又は医療物質の適性に関連する提案及び/又は情報を提供するための方法及びシステム |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009123233A JP2009123233A (ja) | 2009-06-04 |
JP5269633B2 true JP5269633B2 (ja) | 2013-08-21 |
Family
ID=8562597
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003556935A Withdrawn JP2005513678A (ja) | 2001-12-28 | 2002-12-23 | 情報サービスを配列して栄養及び/又は薬剤を決定するための方法及び機構 |
JP2009020021A Expired - Fee Related JP5269633B2 (ja) | 2001-12-28 | 2009-01-30 | 栄養素及び/又は医療物質の適性に関連する提案及び/又は情報を提供するための方法及びシステム |
JP2012231808A Pending JP2013037724A (ja) | 2001-12-28 | 2012-10-19 | 栄養素及び/又は医療物質の適性に関連する提案及び/又は情報を提供するための方法及びシステム |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003556935A Withdrawn JP2005513678A (ja) | 2001-12-28 | 2002-12-23 | 情報サービスを配列して栄養及び/又は薬剤を決定するための方法及び機構 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012231808A Pending JP2013037724A (ja) | 2001-12-28 | 2012-10-19 | 栄養素及び/又は医療物質の適性に関連する提案及び/又は情報を提供するための方法及びシステム |
Country Status (8)
Country | Link |
---|---|
US (3) | US8560334B2 (ja) |
EP (1) | EP1470515A1 (ja) |
JP (3) | JP2005513678A (ja) |
CN (2) | CN102768712A (ja) |
AU (1) | AU2002352306A1 (ja) |
CA (1) | CA2471650C (ja) |
FI (1) | FI20012593A0 (ja) |
WO (1) | WO2003056492A1 (ja) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7156809B2 (en) | 1999-12-17 | 2007-01-02 | Q-Tec Systems Llc | Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity |
FI20012593A0 (fi) * | 2001-12-28 | 2001-12-28 | Pertti Laehteenmaeki | Menetelmä ja järjestelmä ravitsemustietopalvelun järjestämiseksi |
JP2007505404A (ja) * | 2003-09-12 | 2007-03-08 | アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー | 健康状態を整えるためのプログラム |
WO2005036444A1 (en) * | 2003-10-17 | 2005-04-21 | National University Of Singapore | Apparatus and method for determining the health effects associated with various products |
EP1630753A1 (fr) * | 2004-08-26 | 2006-03-01 | polyright SA | Méthode de gestion de l'accès à une prestation ou à un produit |
US7505989B2 (en) | 2004-09-03 | 2009-03-17 | Biowisdom Limited | System and method for creating customized ontologies |
US20060053382A1 (en) * | 2004-09-03 | 2006-03-09 | Biowisdom Limited | System and method for facilitating user interaction with multi-relational ontologies |
US7496593B2 (en) * | 2004-09-03 | 2009-02-24 | Biowisdom Limited | Creating a multi-relational ontology having a predetermined structure |
US20060074833A1 (en) * | 2004-09-03 | 2006-04-06 | Biowisdom Limited | System and method for notifying users of changes in multi-relational ontologies |
US20060053175A1 (en) * | 2004-09-03 | 2006-03-09 | Biowisdom Limited | System and method for creating, editing, and utilizing one or more rules for multi-relational ontology creation and maintenance |
US20060053174A1 (en) * | 2004-09-03 | 2006-03-09 | Bio Wisdom Limited | System and method for data extraction and management in multi-relational ontology creation |
US20060053172A1 (en) * | 2004-09-03 | 2006-03-09 | Biowisdom Limited | System and method for creating, editing, and using multi-relational ontologies |
US20060053099A1 (en) * | 2004-09-03 | 2006-03-09 | Biowisdom Limited | System and method for capturing knowledge for integration into one or more multi-relational ontologies |
US7493333B2 (en) * | 2004-09-03 | 2009-02-17 | Biowisdom Limited | System and method for parsing and/or exporting data from one or more multi-relational ontologies |
US7762181B2 (en) | 2004-10-01 | 2010-07-27 | Fonterra Co-Operative Group Limited | Customised nutritional food and beverage dispensing system |
DE102004060314A1 (de) * | 2004-12-08 | 2006-08-31 | Beiersdorf Ag | Wirkstoffkombinationen aus einem oder mehreren Isoflavonoiden und Carnitin und/oder einem oder mehreren Acyl-Carnitinen |
JP2007034845A (ja) * | 2005-07-28 | 2007-02-08 | Genesis Healthcare Kk | 健康支援情報提供方法,健康支援情報提供装置,健康支援情報提供プログラム |
US7941200B2 (en) * | 2005-12-08 | 2011-05-10 | Roche Diagnostics Operations, Inc. | System and method for determining drug administration information |
US20080296380A1 (en) * | 2007-05-29 | 2008-12-04 | Microsoft Corporation | Nutritional intake tracker |
US20090006127A1 (en) * | 2007-06-27 | 2009-01-01 | Mory Bahar | Personalized nutrition advisor |
US20100125782A1 (en) * | 2008-11-14 | 2010-05-20 | Howard Jay Snortland | Electronic document for automatically determining a dosage for a treatment |
US20100125421A1 (en) * | 2008-11-14 | 2010-05-20 | Howard Jay Snortland | System and method for determining a dosage for a treatment |
US20120072233A1 (en) * | 2010-09-20 | 2012-03-22 | Hanlon Alaina B | Medical health information system for health assessment, weight management and meal planning |
US20110084132A1 (en) * | 2009-10-08 | 2011-04-14 | At&T Intellectual Property I, L.P. | Devices, Systems and Methods for Secure Remote Medical Diagnostics |
US20110166881A1 (en) * | 2010-01-07 | 2011-07-07 | Paul Eugene Brazzo | Method and system for generating food recommendations |
WO2013085047A1 (ja) * | 2011-12-09 | 2013-06-13 | 味の素株式会社 | 食物選択方法、食物選択装置、食物選択プログラム、食物選択システムおよび情報通信端末 |
RU2014137453A (ru) * | 2012-02-17 | 2016-04-10 | Пепсико, Инк. | Способ управления потреблением человеком веществ, выделяющих энергию, для улучшения спортивной подготовки |
KR101444104B1 (ko) * | 2012-08-01 | 2014-09-30 | 삼성전자주식회사 | 사용자 인터페이스 생성 방법 및 그에 따른 사용자 인터페이스 생성 장치 |
US20140052458A1 (en) * | 2012-08-20 | 2014-02-20 | WellCube Healthcare Corporation | Techniques for customizing and delivering wellness products and services |
CN105263376B (zh) * | 2013-06-07 | 2018-12-21 | 雀巢产品技术援助有限公司 | 用于确定补充信息的方法和系统 |
US20160203352A1 (en) * | 2013-09-20 | 2016-07-14 | Flashback Survey, Inc. | Using scanable codes to obtain a service |
CN103544224A (zh) * | 2013-10-07 | 2014-01-29 | 宁波芝立软件有限公司 | 一种收养关系信息存储表示方法、系统及设备 |
BR112018001335A2 (pt) * | 2015-07-22 | 2018-09-11 | Biomerica Inc | sistema e método para fornecer uma recomendação alimentar baseada em testes de sensibilidade alimentar |
CN105342856A (zh) * | 2015-12-11 | 2016-02-24 | 上海众心和医药科技有限公司 | 全自动中药汤剂制药装置 |
US20170221296A1 (en) | 2016-02-02 | 2017-08-03 | 6d bytes inc. | Automated preparation and dispensation of food and beverage products |
US20170243513A1 (en) * | 2016-02-19 | 2017-08-24 | David L. Katz | Diet Quality Photo Navigation |
EP3529379B1 (en) | 2016-10-24 | 2022-05-18 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | System and method for implementing meal selection based on vitals, genotype, and phenotype |
JP2018124702A (ja) * | 2017-01-31 | 2018-08-09 | 株式会社教育ソフトウェア | 病因分析装置および疾病予測装置 |
CN108629149B (zh) * | 2017-03-21 | 2023-04-07 | 达易特基因科技股份有限公司 | 基因检测平台方法 |
EP3625615A1 (en) | 2017-05-19 | 2020-03-25 | Dqpn, Llc | Diet mapping processes and systems to optimize diet quality and/or minimize environmental impact |
US10815044B2 (en) | 2018-04-04 | 2020-10-27 | 6D Bytes, Inc. | Automated food production kiosk |
US11142412B2 (en) | 2018-04-04 | 2021-10-12 | 6d bytes inc. | Dispenser |
US10991463B2 (en) | 2018-05-18 | 2021-04-27 | John D. Kutzko | Computer-implemented system and methods for predicting the health and therapeutic behavior of individuals using artificial intelligence, smart contracts and blockchain |
KR20210019109A (ko) * | 2018-07-06 | 2021-02-19 | 더 코카콜라 컴파니 | 음료 분배기 네트워크 및 프로파일 관리 |
WO2020069500A1 (en) * | 2018-09-30 | 2020-04-02 | Yibing Hu | Smart health expert and manager |
US11392854B2 (en) | 2019-04-29 | 2022-07-19 | Kpn Innovations, Llc. | Systems and methods for implementing generated alimentary instruction sets based on vibrant constitutional guidance |
CN110391011A (zh) * | 2019-06-14 | 2019-10-29 | 上海中优精准医疗科技股份有限公司 | 轻断食个性化干预方案管理系统 |
US11114193B2 (en) | 2019-07-03 | 2021-09-07 | Kpn Innovations, Llc | Methods and systems for optimizing dietary levels utilizing artificial intelligence |
US11610683B2 (en) * | 2019-08-05 | 2023-03-21 | Kpn Innovations, Llc. | Methods and systems for generating a vibrant compatibility plan using artificial intelligence |
US10832172B1 (en) | 2019-08-22 | 2020-11-10 | Kpn Innovations, Llc. | Systems and methods for arranging transport of adapted nutrimental artifacts with user-defined restriction requirements using artificial intelligence |
US11929161B2 (en) | 2019-08-22 | 2024-03-12 | Kpn Innovations, Llc | Systems and methods for displaying nutrimental artifacts on a user device |
US11424019B2 (en) * | 2020-01-22 | 2022-08-23 | Rockspoon, Inc. | System and methods for personal food item customization |
US11964247B2 (en) | 2020-03-06 | 2024-04-23 | 6d bytes inc. | Automated blender system |
US11862322B2 (en) | 2020-11-30 | 2024-01-02 | Kpn Innovations, Llc. | System and method for generating a dynamic weighted combination |
US11270789B1 (en) * | 2020-11-30 | 2022-03-08 | Kpn Innovations, Llc. | Methods and systems for timing impact of nourishment consumpiion |
US11854684B2 (en) | 2020-12-29 | 2023-12-26 | Kpn Innovations, Llc. | Methods and systems for nourishment refinement using psychiatric markers |
US11164669B1 (en) | 2020-12-29 | 2021-11-02 | Kpn Innovations, Llc. | Systems and methods for generating a viral alleviation program |
US20220208375A1 (en) * | 2020-12-29 | 2022-06-30 | Kpn Innovations, Llc. | System and method for generating a digestive disease functional program |
US11158417B1 (en) * | 2020-12-29 | 2021-10-26 | Kpn Innovations, Llc. | System and method for generating a digestive disease nourishment program |
US20230017308A1 (en) * | 2021-07-14 | 2023-01-19 | At&T Intellectual Property I, L.P. | Method and apparatus for virtual healthcare assistant |
US11600375B2 (en) | 2021-07-30 | 2023-03-07 | Reviv Global Ltd | Genetically personalized food recommendation systems and methods |
US11894121B2 (en) | 2021-08-06 | 2024-02-06 | Reviv Global Ltd | Prescriptive nutrition-based IV and IM infusion treatment formula creation systems and methods |
US11337547B1 (en) * | 2021-12-14 | 2022-05-24 | Cana Technology, Inc. | Ingredient level consumption guidance in a beverage dispensing system |
CN115831322B (zh) * | 2023-01-09 | 2023-07-21 | 上海楚动智能科技有限公司 | 一种基于自动化营养配置的营养方案生成方法及系统 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0427875A4 (en) | 1989-06-05 | 1993-01-27 | Otsuka Pharmaceutical Co., Ltd. | Health management system |
US6024281A (en) * | 1989-09-27 | 2000-02-15 | Shepley; Kenneth James | Nutritional information system for shoppers |
US5233520A (en) * | 1990-12-19 | 1993-08-03 | The United States Of America As Represented By The Secretary Of Agriculture | Method and system for measurement of intake of foods, nutrients and other food components in the diet |
US5390238A (en) * | 1992-06-15 | 1995-02-14 | Motorola, Inc. | Health support system |
AU673369B2 (en) * | 1992-06-22 | 1996-11-07 | Health Risk Management, Inc. | Health care management system |
SE500122C2 (sv) * | 1992-08-27 | 1994-04-18 | Rudolf Valentin Sillen | Förfarande och anordning för individuellt styrd, adaptiv medicinering |
US5985559A (en) * | 1997-04-30 | 1999-11-16 | Health Hero Network | System and method for preventing, diagnosing, and treating genetic and pathogen-caused disease |
US5412564A (en) * | 1994-02-03 | 1995-05-02 | Ecer; Gunes M. | System and method for diet control |
JPH07271857A (ja) | 1994-03-29 | 1995-10-20 | Olympus Optical Co Ltd | 統合栄養管理カードシステム |
US5836312A (en) * | 1996-01-02 | 1998-11-17 | Moore; Steven Jerome | Computer-assisted system and method for adjudging the effect of consumable intakes on physiological parameters |
US6678669B2 (en) * | 1996-02-09 | 2004-01-13 | Adeza Biomedical Corporation | Method for selecting medical and biochemical diagnostic tests using neural network-related applications |
WO1997040462A2 (en) * | 1996-04-19 | 1997-10-30 | Spectra Biomedical, Inc. | Correlating polymorphic forms with multiple phenotypes |
US5819735A (en) * | 1996-08-15 | 1998-10-13 | Mansfield; Elizabeth A. | Device and method for monitoring dietary intake of calories and nutrients |
US6056690A (en) * | 1996-12-27 | 2000-05-02 | Roberts; Linda M. | Method of diagnosing breast cancer |
US6000828A (en) * | 1997-08-22 | 1999-12-14 | Power Med Incorporated | Method of improving drug treatment |
JPH11262649A (ja) * | 1998-03-18 | 1999-09-28 | Omron Corp | 混合装置および方法、ならびに飲料供給装置 |
IL138620A0 (en) * | 1998-04-03 | 2001-10-31 | Triangle Pharmaceuticals Inc | Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens |
US6038546A (en) * | 1998-07-08 | 2000-03-14 | Jay Ferro | System and method for creating a food order sales receipt identifying nutritional information of a customized meal |
US6272472B1 (en) * | 1998-12-29 | 2001-08-07 | Intel Corporation | Dynamic linking of supplier web sites to reseller web sites |
GB9904585D0 (en) * | 1999-02-26 | 1999-04-21 | Gemini Research Limited | Clinical and diagnostic database |
US20010034023A1 (en) * | 1999-04-26 | 2001-10-25 | Stanton Vincent P. | Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing |
CN1312468A (zh) * | 2000-03-08 | 2001-09-12 | 郑东 | 一种可提出治疗保健建议的基因诊断仪 |
JP2001256305A (ja) * | 2000-03-13 | 2001-09-21 | Kazutoshi Mogi | 遺伝子検査データ活用方法 |
US7024369B1 (en) * | 2000-05-31 | 2006-04-04 | International Business Machines Corporation | Balancing the comprehensive health of a user |
ES2334011T3 (es) * | 2000-06-08 | 2010-03-04 | Virco Bvba | Metodo para predecir la resistencia a los agentes terapeuticos utilizando redes neurales. |
EP1176539A1 (en) * | 2000-07-13 | 2002-01-30 | Virology Networks B.V. | Method for effecting computer implemented decision-support in the selection of the drug therapy of patients having a viral disease |
DE10035702A1 (de) * | 2000-07-20 | 2002-02-21 | Epl Medizintechnische Produkti | Verfahren und Vorrichtung zur Ermittlung von Daten zur Ernährung und/oder Gesunderhaltung |
JP2004517394A (ja) * | 2000-11-02 | 2004-06-10 | エピゲノミクス アーゲー | Dnaのメチル化状態に基づく治療法の選択のガイドのためのシステム、方法及びコンピュータープログラム |
US20020082869A1 (en) * | 2000-12-27 | 2002-06-27 | Gateway, Inc. | Method and system for providing and updating customized health care information based on an individual's genome |
JP2002358362A (ja) * | 2001-03-13 | 2002-12-13 | Daikokudoo Medical:Kk | 郵送遺伝子検査システム |
US7529685B2 (en) * | 2001-08-28 | 2009-05-05 | Md Datacor, Inc. | System, method, and apparatus for storing, retrieving, and integrating clinical, diagnostic, genomic, and therapeutic data |
FI20012593A0 (fi) * | 2001-12-28 | 2001-12-28 | Pertti Laehteenmaeki | Menetelmä ja järjestelmä ravitsemustietopalvelun järjestämiseksi |
US20030158465A1 (en) * | 2002-02-15 | 2003-08-21 | Galli Doreen L. | Method and system for facilitating compliance with a dietary restriction |
-
2001
- 2001-12-28 FI FI20012593A patent/FI20012593A0/fi unknown
-
2002
- 2002-12-23 CN CN2012100885275A patent/CN102768712A/zh active Pending
- 2002-12-23 CN CNA028263383A patent/CN1610919A/zh active Pending
- 2002-12-23 EP EP20020788017 patent/EP1470515A1/en not_active Ceased
- 2002-12-23 AU AU2002352306A patent/AU2002352306A1/en not_active Abandoned
- 2002-12-23 WO PCT/FI2002/001055 patent/WO2003056492A1/en active Application Filing
- 2002-12-23 JP JP2003556935A patent/JP2005513678A/ja not_active Withdrawn
- 2002-12-23 CA CA2471650A patent/CA2471650C/en not_active Expired - Fee Related
- 2002-12-26 US US10/328,044 patent/US8560334B2/en active Active
-
2009
- 2009-01-30 JP JP2009020021A patent/JP5269633B2/ja not_active Expired - Fee Related
-
2012
- 2012-10-19 JP JP2012231808A patent/JP2013037724A/ja active Pending
-
2013
- 2013-03-21 US US13/848,123 patent/US20130218602A1/en not_active Abandoned
-
2016
- 2016-06-24 US US15/192,141 patent/US20160306931A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003056492A1 (en) | 2003-07-10 |
CA2471650A1 (en) | 2003-07-10 |
CA2471650C (en) | 2017-07-11 |
EP1470515A1 (en) | 2004-10-27 |
CN102768712A (zh) | 2012-11-07 |
FI20012593A0 (fi) | 2001-12-28 |
JP2005513678A (ja) | 2005-05-12 |
US20160306931A1 (en) | 2016-10-20 |
CN1610919A (zh) | 2005-04-27 |
US8560334B2 (en) | 2013-10-15 |
US20030182160A1 (en) | 2003-09-25 |
US20130218602A1 (en) | 2013-08-22 |
JP2013037724A (ja) | 2013-02-21 |
AU2002352306A1 (en) | 2003-07-15 |
JP2009123233A (ja) | 2009-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5269633B2 (ja) | 栄養素及び/又は医療物質の適性に関連する提案及び/又は情報を提供するための方法及びシステム | |
JP5031179B2 (ja) | データベース機構を利用して最適な投与量の栄養を生成するための栄養ディスペンサ及び方法 | |
US11791045B1 (en) | Apparatus for informed personal well-being decision making and associated method | |
US6510430B1 (en) | Diagnosis and interpretation methods and apparatus for a personal nutrition program | |
JP6112591B1 (ja) | 創作物供給システム | |
US20120290327A1 (en) | Medical health information system for health assessment, weight management and meal planning | |
KR20200117218A (ko) | 개인 맞춤형 건강기능식품 추천방법 및 이를 이용한 건강기능식품 추천 시스템 | |
Jang et al. | Characteristics of herbal medicine users and adverse events experienced in South Korea: a survey study | |
Dwyer et al. | Food and dietary supplement databases for what we eat in America–NHANES | |
JP7096056B2 (ja) | 買い物支援システム、買い物支援サーバ、プログラム及びユーザ端末。 | |
Chalermsri et al. | Socio-demographic characteristics associated with the dietary diversity of Thai community-dwelling older people: results from the national health examination survey | |
JP6112590B1 (ja) | 創作物供給装置、及び創作物供給システム | |
Bauchet et al. | The effect of gender targeting of food transfers on child nutritional status: experimental evidence from the Bolivian amazon | |
JP7374579B2 (ja) | 買い物支援システム、買い物支援サーバ、プログラム及びユーザ端末。 | |
Situmorang et al. | Purchase Intention on Sustainable products: A Case study on Free-Range Eggs in Taiwan | |
KR20200134783A (ko) | 건강기능식품 추천구매에 대한 보상방법 및 이를 이용한 건강기능식품 추천 보상 시스템 | |
WO2022061626A1 (zh) | 一种个体化口味管理的方法及系统 | |
Jafree | Food Security, Nutrition, and Social Policy for Women of Pakistan | |
JP2003216735A (ja) | 高機能作物の販売・栽培管理システム | |
JP2020135721A (ja) | 買い物支援システム、買い物支援サーバ、プログラム及びユーザ端末 | |
US20220262495A1 (en) | User auxiliary information output device, user auxiliary information output system, and user auxiliary information output method | |
GB2524103A (en) | Real-time systems and methods for management of alimentation | |
Stahl et al. | LIFANA–User-Centered Design of a Personalized Meal Recommender App for the Elderly | |
TH16093C3 (th) | ระบบประเมินภาวะโภชนาการ พร้อมกำหนดอาหารหรือแนะนำโภชนาการที่เหมาะสมกับสุขภาพส่วนบุคคล | |
TH16093A3 (th) | ระบบประเมินภาวะโภชนาการ พร้อมกำหนดอาหารหรือแนะนำโภชนาการที่เหมาะสมกับสุขภาพส่วนบุคคล |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090416 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110322 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110602 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110607 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110922 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120619 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121019 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121025 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20121030 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130104 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130319 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130409 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130508 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5269633 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |